Catheter utilizing optical spectroscopy for measuring tissue contact area

(19)

(11)

EP 2 889 013 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	18.07.2018 Bulletin 2018/29

(45)	Mention of the grant of the patent:
	30.05.2018 Bulletin 2018/22

(21)	Application number: 14200527.1

(22)	Date of filing: 30.12.2014

(51)

International Patent Classification (IPC):

A61B 18/14^(2006.01)
A61B 5/145^(2006.01)
A61B 18/00^(2006.01)

A61B 5/00^(2006.01)
A61B 5/1459^(2006.01)

(54)	Catheter utilizing optical spectroscopy for measuring tissue contact area Katheter mit optischer Spektroskopie zur Messung der Gewebekontaktfläche Cathéter utilisant une spectroscopie optique pour la mesure de zone de contact de tissu

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

31.12.2013 US 201314145858

(43)	Date of publication of application:
	01.07.2015 Bulletin 2015/27

(60)	Divisional application:
	18174951.6

(73)	Proprietor: Biosense Webster (Israel) Ltd.
	2066717 Yokneam (IL)

(72)	Inventors:
	Ashton, John, H. Glendora, CA 91740 (US) Clark, Jeffrey, L. Castaic, CA 91384 (US) Kamin, George Arcadia, CA 91007 (US) Keyes, Joseph Glendora, CA 91741 (US)

(74)	Representative: Carpmaels & Ransford LLP
	One Southampton Row London WC1B 5HA London WC1B 5HA (GB)

(56)

References cited: :

EP-A1- 2 008 603
US-A1- 2007 287 998
US-A1- 2012 265 184

EP-A2- 2 062 545
US-A1- 2009 005 768

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).